Ryohei Yamamoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ryohei Yamamoto has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Kazuyuki Numakura
Department of Renal and Urologic Surgery Asahikawa Medical University Asahikawa Japan
8 shared publications - Shintaro Narita
Department of Urology, Akita University Graduate School of Medicine, Akita, Japan
5 shared publications - Tomonori Habuchi
Department of Urology, Akita University Graduate School of Medicine, Akita, Japan
5 shared publications - Hiromi Sato
Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan
4 shared publications - Mitsuru Saito
Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan
4 shared publications Tomonori Habuchi
Department of Urology Akita University Graduate School of Medicine Akita Japan
4 shared publications
Latest Publications
- 12 November 2026
- Published by Oxford University Press (OUP) in Carcinogenesis
Lard-Based Diet Promotes Prostate Cancer Progression through Gut microbiota-Driven Immune Suppression in the Tumor Microenvironment
Growing epidemiological evidence indicates that dietary fats and obesity are linked to prostate cancer (PCa) progression. This study examines the impact of a lard-based diet (LD) on PCa progression through gut microbiota alterations and immune modulation. Using a prostate-specific Pten knockout mouse model, LD increased the relative abundance of the phylum Proteobacteria, which correlated with higher serum lipopolysaccharide (LPS) levels, weight gain, activation of TGF-β signaling, and accelerated PCa growth. Moreover, LD promoted Foxp3+ T cell infiltration within tumors, enhancing the immunosuppressive tumor microenvironment and driving cancer progression. Antibiotic treatment reduced both Foxp3+ T cell infiltration and serum LPS levels, highlighting the role of gut microbiota in PCa progression. Moreover, inhibiting LPS signaling suppressed high-fat diet-induced Foxp3+ T cell infiltration. In clinical samples, obesity was associated with increased FOXP3+ T cell infiltration in the prostate, while an abundance of gut class ε-Proteobacteria correlated with obesogenic phenotypes and advanced PCa features. These findings suggest that LD-induced gut microbiota changes and immune modulation contribute to PCa progression via systemic inflammation and intratumoral TGF-β signaling, presenting a potential preventive and therapeutic target for PCa.
- 12 November 2026
- Published by Oxford University Press (OUP) in Carcinogenesis
Lard-Based Diet Promotes Prostate Cancer Progression through Gut microbiota-Driven Immune Suppression in the Tumor Microenvironment
Growing epidemiological evidence indicates that dietary fats and obesity are linked to prostate cancer (PCa) progression. This study examines the impact of a lard-based diet (LD) on PCa progression through gut microbiota alterations and immune modulation. Using a prostate-specific Pten knockout mouse model, LD increased the relative abundance of the phylum Proteobacteria, which correlated with higher serum lipopolysaccharide (LPS) levels, weight gain, activation of TGF-β signaling, and accelerated PCa growth. Moreover, LD promoted Foxp3+ T cell infiltration within tumors, enhancing the immunosuppressive tumor microenvironment and driving cancer progression. Antibiotic treatment reduced both Foxp3+ T cell infiltration and serum LPS levels, highlighting the role of gut microbiota in PCa progression. Moreover, inhibiting LPS signaling suppressed high-fat diet-induced Foxp3+ T cell infiltration. In clinical samples, obesity was associated with increased FOXP3+ T cell infiltration in the prostate, while an abundance of gut class ε-Proteobacteria correlated with obesogenic phenotypes and advanced PCa features. These findings suggest that LD-induced gut microbiota changes and immune modulation contribute to PCa progression via systemic inflammation and intratumoral TGF-β signaling, presenting a potential preventive and therapeutic target for PCa.
- Open Access
- 8 October 2026
- Published by Wiley in IJU Case Reports
- Vol. 9 (6)
Spontaneous Rupture of a Small Chromophobe Renal Cell Carcinoma Presenting as Wunderlich Syndrome
Introduction: Chromophobe renal cell carcinoma rarely causes spontaneous renal hemorrhage and enhances weakly on computed tomography. We report a case in which the tumor was masked by a perirenal hematoma for 11 months. Case Presentation: A 46‐year‐old woman presented with spontaneous renal hemorrhage and no visible renal mass. Magnetic resonance imaging (MRI) at 6 months showed an enhancing lesion indistinguishable from organizing hematoma; because it was shrinking with the hematoma, observation was continued. At 11 months, the hematoma had resolved and a 25‐mm solid mass remained. Partial nephrectomy revealed pT1a chromophobe renal cell carcinoma without necrosis or sarcomatoid differentiation. She remained recurrence‐free at 5 years. Conclusion: This case demonstrates spontaneous rupture of a small tumor without aggressive pathological features. When the cause of spontaneous renal hemorrhage remains unclear, serial imaging should be considered until hematoma resolution to avoid missing an occult malignancy.
- 8 October 2026
- Published by Wiley in IJU Case Reports
- Vol. 9 (6)
Open AccessSpontaneous Rupture of a Small Chromophobe Renal Cell Carcinoma Presenting as Wunderlich Syndrome
Introduction: Chromophobe renal cell carcinoma rarely causes spontaneous renal hemorrhage and enhances weakly on computed tomography. We report a case in which the tumor was masked by a perirenal hematoma for 11 months. Case Presentation: A 46‐year‐old woman presented with spontaneous renal hemorrhage and no visible renal mass. Magnetic resonance imaging (MRI) at 6 months showed an enhancing lesion indistinguishable from organizing hematoma; because it was shrinking with the hematoma, observation was continued. At 11 months, the hematoma had resolved and a 25‐mm solid mass remained. Partial nephrectomy revealed pT1a chromophobe renal cell carcinoma without necrosis or sarcomatoid differentiation. She remained recurrence‐free at 5 years. Conclusion: This case demonstrates spontaneous rupture of a small tumor without aggressive pathological features. When the cause of spontaneous renal hemorrhage remains unclear, serial imaging should be considered until hematoma resolution to avoid missing an occult malignancy.
- Open Access
- 4 September 2026
- Published by Elsevier in SSRN Electronic Journal
Successful Kidney Transplant From a Living Donor Involving Five Renal Arteries, Two Renal Veins, and a Duplicated Inferior Vena Cava: A Case Report
Multiple renal arteries and a duplicated inferior vena cava can complicate laparoscopic donor nephrectomy and graft implantation. We report living donor kidney transplantation from a 60-year-old man to his 22-year-old daughter. Preoperative three-dimensional computed tomography revealed five left renal arteries, two left renal veins, and a duplicated inferior vena cava. During transperitoneal laparoscopic donor nephrectomy and bench surgery, two 1-mm caliber superior polar arteries supplying 6.5% of the renal parenchyma were ligated, whereas the inferior polar artery was preserved to maintain potential ureteral perfusion. The three remaining arteries were reconstructed into one arterial orifice, and the two renal veins were conjoined into one venous orifice. The graft demonstrated immediate reperfusion and urine production. A 1-hour biopsy showed only mild acute tubular necrosis. At 1 year, the serum creatinine level was 1.17 mg/dL, and the estimated glomerular filtration rate was 49.1 mL/min/1.73 m2 . This living donation complied with the Declaration of Helsinki and the Declaration of Istanbul; the organ was not obtained from a prisoner or from a coerced or paid donor.
- 4 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSuccessful Kidney Transplant From a Living Donor Involving Five Renal Arteries, Two Renal Veins, and a Duplicated Inferior Vena Cava: A Case Report
Multiple renal arteries and a duplicated inferior vena cava can complicate laparoscopic donor nephrectomy and graft implantation. We report living donor kidney transplantation from a 60-year-old man to his 22-year-old daughter. Preoperative three-dimensional computed tomography revealed five left renal arteries, two left renal veins, and a duplicated inferior vena cava. During transperitoneal laparoscopic donor nephrectomy and bench surgery, two 1-mm caliber superior polar arteries supplying 6.5% of the renal parenchyma were ligated, whereas the inferior polar artery was preserved to maintain potential ureteral perfusion. The three remaining arteries were reconstructed into one arterial orifice, and the two renal veins were conjoined into one venous orifice. The graft demonstrated immediate reperfusion and urine production. A 1-hour biopsy showed only mild acute tubular necrosis. At 1 year, the serum creatinine level was 1.17 mg/dL, and the estimated glomerular filtration rate was 49.1 mL/min/1.73 m2 . This living donation complied with the Declaration of Helsinki and the Declaration of Istanbul; the organ was not obtained from a prisoner or from a coerced or paid donor.
- Open Access
- 4 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1238
Clinical Impact of Preoperative Obesity on Living-Donor Kidney Transplant Recipients in Japan: A Multicenter Experience
Background: Obesity is increasingly prevalent among kidney transplant candidates; however, its impact on graft outcomes in Asian populations is not well characterized. We evaluated the association between preoperative obesity and living-donor kidney transplantation outcomes in Japan. Methods: We analyzed 623 living-donor kidney transplants performed from 1998 to 2021 at six centers in northern Japan. Recipients were categorized by body mass index (BMI) at transplant, and multivariable Cox regression was employed for assessing graft outcomes. Results: Obesity (BMI, ≥30 kg/m2; n = 27 [4.3%]) was the strongest graft failure predictor (hazard ratio, 4.62) compared with normal-weight recipients. Moreover, overweight status (BMI, 25–29.9 kg/m2), acute rejection, and older donor age were independent risk factors. Despite similar rejection rates across the BMI groups, recipients with obesity exhibited persistently impaired kidney function from 1-week posttransplant to the 5-year follow-up. Patient survival was comparable across BMI groups; however, underweight status (BMI < 18.5 kg/m2) was associated with higher mortality. Conclusions: Preoperative obesity and overweight status were significant risk factors for graft failure in Japanese living-donor kidney transplant recipients. Meanwhile, the mortality rate was significantly higher in the patients with underweight status at transplant. Pre-transplant weight optimization and shared decision-making with candidates warrant consideration.
- 4 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1238
Open AccessClinical Impact of Preoperative Obesity on Living-Donor Kidney Transplant Recipients in Japan: A Multicenter Experience
Background: Obesity is increasingly prevalent among kidney transplant candidates; however, its impact on graft outcomes in Asian populations is not well characterized. We evaluated the association between preoperative obesity and living-donor kidney transplantation outcomes in Japan. Methods: We analyzed 623 living-donor kidney transplants performed from 1998 to 2021 at six centers in northern Japan. Recipients were categorized by body mass index (BMI) at transplant, and multivariable Cox regression was employed for assessing graft outcomes. Results: Obesity (BMI, ≥30 kg/m2; n = 27 [4.3%]) was the strongest graft failure predictor (hazard ratio, 4.62) compared with normal-weight recipients. Moreover, overweight status (BMI, 25–29.9 kg/m2), acute rejection, and older donor age were independent risk factors. Despite similar rejection rates across the BMI groups, recipients with obesity exhibited persistently impaired kidney function from 1-week posttransplant to the 5-year follow-up. Patient survival was comparable across BMI groups; however, underweight status (BMI < 18.5 kg/m2) was associated with higher mortality. Conclusions: Preoperative obesity and overweight status were significant risk factors for graft failure in Japanese living-donor kidney transplant recipients. Meanwhile, the mortality rate was significantly higher in the patients with underweight status at transplant. Pre-transplant weight optimization and shared decision-making with candidates warrant consideration.
- Open Access
- 31 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10621
Inhibition of Fatty Acid-Binding Protein 4 Limits High-Fat-Diet-Associated Prostate Tumorigenesis and Progression in TRAMP Mice
Fatty acid-binding protein 4 (FABP4) is an important adipokine associated with inflammatory responses and metabolic regulation. Although a high-fat diet (HF) and/or HF-mediated obesity have been clearly linked to the progression of prostate cancer, with FABP4 potentially playing a critical role in this relationship, the mechanisms by which FABP4 facilitates this interaction remain unclear. After generating FABP4 knockout (FABP4−/−) transgenic adenocarcinoma of the mouse prostate (TRAMP) mice, it was found that FABP4−/− TRAMP mice presented significantly ameliorated prostate tumorigenesis and tumor progression along with decreased body weight, protumorigenic cytokine secretion, and pan-amino acid synthesis when compared to TRAMP mice under the HF condition. Additionally, treatment with BMS309403—a chemical inhibitor of FABP4—was observed to abrogate the HF-mediated TRAMP tumor progression, along with reductions in body weight and cytokine production. Thus, FABP4 plays an essential role in the progression of HF-mediated prostate cancer through the modulation of metabolic and inflammatory pathways, providing a potential therapeutic target for prostate cancer.
- 31 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10621
Open AccessInhibition of Fatty Acid-Binding Protein 4 Limits High-Fat-Diet-Associated Prostate Tumorigenesis and Progression in TRAMP Mice
Fatty acid-binding protein 4 (FABP4) is an important adipokine associated with inflammatory responses and metabolic regulation. Although a high-fat diet (HF) and/or HF-mediated obesity have been clearly linked to the progression of prostate cancer, with FABP4 potentially playing a critical role in this relationship, the mechanisms by which FABP4 facilitates this interaction remain unclear. After generating FABP4 knockout (FABP4−/−) transgenic adenocarcinoma of the mouse prostate (TRAMP) mice, it was found that FABP4−/− TRAMP mice presented significantly ameliorated prostate tumorigenesis and tumor progression along with decreased body weight, protumorigenic cytokine secretion, and pan-amino acid synthesis when compared to TRAMP mice under the HF condition. Additionally, treatment with BMS309403—a chemical inhibitor of FABP4—was observed to abrogate the HF-mediated TRAMP tumor progression, along with reductions in body weight and cytokine production. Thus, FABP4 plays an essential role in the progression of HF-mediated prostate cancer through the modulation of metabolic and inflammatory pathways, providing a potential therapeutic target for prostate cancer.
- 12 September 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 595
Reassessment of T1a cutoff for kidney cancer in the robotic era
In 2002, the renal cancer T classification was revised by dividing T1 into T1a and T1b at a 4 cm cutoff. However, local treatment using minimally invasive procedures resulted in better outcomes for tumors smaller than 3 cm, leading the European Association of Urology guideline committee to propose a 3 cm cutoff for T1a/b. Nonetheless, the impact of changing the T1 cutoff on robot-assisted partial nephrectomy (RALPN) has not been fully investigated. This study included 300 out of 335 patients with clinical stage T1 disease who underwent RALPN at our institution between November 2013 and April 2024. We evaluated the discriminative performance of clinical outcomes in each group using tumor diameter cutoffs of 4 and 3 cm. Using a 3 cm cutoff, patients with tumors ≥ 3 cm showed a greater decline in estimated glomerular filtration rate (eGFR) (e.g., the change from baseline to 1-year follow-up) ( - 9.6% vs. - 4.9%, p = 0.003) and a higher incidence of overall complications (25% vs. 15%, p = 0.040) compared to those with smaller tumors. With a 4 cm cutoff, differences in eGFR decline ( - 7.8% vs. - 6.7%, p = 0.134) and overall complications (27% vs. 17%, p = 0.100) were not significant. The 3 cm cutoff more accurately predicted overall complications with a higher area under the curve (0.575 vs. 0.451, p = 0.037). A 3 cm cutoff for the T classification of kidney cancer may more accurately predict postoperative renal function and the risk of complications.
- 12 September 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 595
Reassessment of T1a cutoff for kidney cancer in the robotic era
In 2002, the renal cancer T classification was revised by dividing T1 into T1a and T1b at a 4 cm cutoff. However, local treatment using minimally invasive procedures resulted in better outcomes for tumors smaller than 3 cm, leading the European Association of Urology guideline committee to propose a 3 cm cutoff for T1a/b. Nonetheless, the impact of changing the T1 cutoff on robot-assisted partial nephrectomy (RALPN) has not been fully investigated. This study included 300 out of 335 patients with clinical stage T1 disease who underwent RALPN at our institution between November 2013 and April 2024. We evaluated the discriminative performance of clinical outcomes in each group using tumor diameter cutoffs of 4 and 3 cm. Using a 3 cm cutoff, patients with tumors ≥ 3 cm showed a greater decline in estimated glomerular filtration rate (eGFR) (e.g., the change from baseline to 1-year follow-up) ( - 9.6% vs. - 4.9%, p = 0.003) and a higher incidence of overall complications (25% vs. 15%, p = 0.040) compared to those with smaller tumors. With a 4 cm cutoff, differences in eGFR decline ( - 7.8% vs. - 6.7%, p = 0.134) and overall complications (27% vs. 17%, p = 0.100) were not significant. The 3 cm cutoff more accurately predicted overall complications with a higher area under the curve (0.575 vs. 0.451, p = 0.037). A 3 cm cutoff for the T classification of kidney cancer may more accurately predict postoperative renal function and the risk of complications.
- Open Access
- 2 April 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-6
Predictive factors of renal function after robot-assisted partial nephrectomy in clinical T1b tumors
Robot-assisted partial nephrectomy (RAPN) has been shown to be a safe and effective method for treatment of small renal tumors, including clinical T1b renal cell carcinoma (RCC); however, the impact of RAPN for cT1b renal tumors on renal function is not well understood. In this retrospective study, 50 patients who underwent RAPN for cT1b renal tumors were evaluated for pre- and post-operative renal function and perioperative clinical factors. Renal function was assessed using the estimated glomerular filtration rate (eGFR) at baseline and on postoperative days (POD) 1, 7, 30, and 180.A significant renal functional decline was defined as ≥ 15% reduction in eGFR at POD180 compared with eGFR at baseline. Logistic regression analyses were used to identify risk factors for renal function decline, including age, sex, RENAL nephrometry score, operative time, and estimated blood loss. The median patient age was 62 years, and the median tumor diameter and RENAL nephrometry score were 44 mm (IQR 43–50) and 8 (IQR 7–9), respectively. Of these patients, 16 (36%) showed a significant renal functional decline at POD 180. In the multivariate analysis, the L component of the RENAL nephrometry score and an estimated blood loss of 200 mL or more were identified as significant risk factors for renal functional decline. These findings suggest that the preoperatively definable L component of the RENAL nephrometry score and intraoperative blood loss, which may be modifiable factors, play significant roles in post-RAPN renal function decline.
- 2 April 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-6
Open AccessPredictive factors of renal function after robot-assisted partial nephrectomy in clinical T1b tumors
Robot-assisted partial nephrectomy (RAPN) has been shown to be a safe and effective method for treatment of small renal tumors, including clinical T1b renal cell carcinoma (RCC); however, the impact of RAPN for cT1b renal tumors on renal function is not well understood. In this retrospective study, 50 patients who underwent RAPN for cT1b renal tumors were evaluated for pre- and post-operative renal function and perioperative clinical factors. Renal function was assessed using the estimated glomerular filtration rate (eGFR) at baseline and on postoperative days (POD) 1, 7, 30, and 180.A significant renal functional decline was defined as ≥ 15% reduction in eGFR at POD180 compared with eGFR at baseline. Logistic regression analyses were used to identify risk factors for renal function decline, including age, sex, RENAL nephrometry score, operative time, and estimated blood loss. The median patient age was 62 years, and the median tumor diameter and RENAL nephrometry score were 44 mm (IQR 43–50) and 8 (IQR 7–9), respectively. Of these patients, 16 (36%) showed a significant renal functional decline at POD 180. In the multivariate analysis, the L component of the RENAL nephrometry score and an estimated blood loss of 200 mL or more were identified as significant risk factors for renal functional decline. These findings suggest that the preoperatively definable L component of the RENAL nephrometry score and intraoperative blood loss, which may be modifiable factors, play significant roles in post-RAPN renal function decline.
- Open Access
- 3 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11742
Effects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients
The purpose of this study was to evaluate the effects of NR1I2 (7635G>A and 8055C>T) and ABCB1 (1236C>T, 2677G>T/A, and 3435C>T) genetic polymorphisms on everolimus pharmacokinetics in 98 Japanese renal transplant patients. On day 15 after everolimus administration, blood samples were collected just prior to and 1, 2, 3, 4, 6, 9, and 12 h after administration. The dose-adjusted area under the blood concentration–time curve (AUC0-12) of everolimus was significantly lower in patients with the NR1I2 8055C/C genotype than in those with other genotypes (p = 0.022) and was significantly higher in male patients than female patients (p = 0.045). Significant correlations between the dose-adjusted AUC0-12 of everolimus and age (p = 0.001), aspartate transaminase (p = 0.001), and alanine transaminase (p = 0.005) were found. In multivariate analysis, aging (p = 0.008) and higher alanine transaminase levels (p = 0.032) were independently predictive of a higher dose-adjusted everolimus AUC0-12. Aging and hepatic dysfunction in patients may need to be considered when evaluating dose reductions in everolimus. In renal transplant patients, management using everolimus blood concentrations after administration may be more important than analysis of NR1I2 8055C>T polymorphism before administration.
- 3 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (19) , 11742
Open AccessEffects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients
The purpose of this study was to evaluate the effects of NR1I2 (7635G>A and 8055C>T) and ABCB1 (1236C>T, 2677G>T/A, and 3435C>T) genetic polymorphisms on everolimus pharmacokinetics in 98 Japanese renal transplant patients. On day 15 after everolimus administration, blood samples were collected just prior to and 1, 2, 3, 4, 6, 9, and 12 h after administration. The dose-adjusted area under the blood concentration–time curve (AUC0-12) of everolimus was significantly lower in patients with the NR1I2 8055C/C genotype than in those with other genotypes (p = 0.022) and was significantly higher in male patients than female patients (p = 0.045). Significant correlations between the dose-adjusted AUC0-12 of everolimus and age (p = 0.001), aspartate transaminase (p = 0.001), and alanine transaminase (p = 0.005) were found. In multivariate analysis, aging (p = 0.008) and higher alanine transaminase levels (p = 0.032) were independently predictive of a higher dose-adjusted everolimus AUC0-12. Aging and hepatic dysfunction in patients may need to be considered when evaluating dose reductions in everolimus. In renal transplant patients, management using everolimus blood concentrations after administration may be more important than analysis of NR1I2 8055C>T polymorphism before administration.
- Open Access
- 17 February 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (4) , 2214
Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression
Lard diet (LD) is a risk factor for prostate cancer (PCa) development and progression. Two immunocompetent mouse models fed with isocaloric specific fat diets (LD) enriched in saturated and monounsaturated fatty acid (SMFA), showed significanftly enhanced PCa progression with weight gain compared with a fish oil diet (FOD). High gut microbial divergency resulted from difference in diets, and the abundance of several bacterial species, such as in the orders Clostridiales and Lactobacillales, was markedly altered in the feces of LD- or FOD-fed mice. The proportion of the order Lactobacillales in the gut was negatively involved in SMFA-induced body weight gain and PCa progression. We found the modulation of lipid metabolism and cholesterol biosynthesis pathways with three and seven commonly up- and downregulated genes in PCa tissues, and some of them correlated with the abundance of the order Lactobacillales in mouse gut. The expression of sphingosine 1-phosphate receptor 2, which is associated with the order Lactobacillales and cancer progression in mouse models, was inversely associated with aggressive phenotype and weight gain in patients with PCa using the NCBI Gene Expression Omnibus database. Therefore, SMFA may promote PCa progression with the abundance of specific gut microbial species and overexpression of lipogenic genes in PCa. Therapeutics with alteration of gut microbiota and candidate genes involved in diet-induced PCa progression may be attractive in PCa.
- 17 February 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (4) , 2214
Open AccessSpecific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression
Lard diet (LD) is a risk factor for prostate cancer (PCa) development and progression. Two immunocompetent mouse models fed with isocaloric specific fat diets (LD) enriched in saturated and monounsaturated fatty acid (SMFA), showed significanftly enhanced PCa progression with weight gain compared with a fish oil diet (FOD). High gut microbial divergency resulted from difference in diets, and the abundance of several bacterial species, such as in the orders Clostridiales and Lactobacillales, was markedly altered in the feces of LD- or FOD-fed mice. The proportion of the order Lactobacillales in the gut was negatively involved in SMFA-induced body weight gain and PCa progression. We found the modulation of lipid metabolism and cholesterol biosynthesis pathways with three and seven commonly up- and downregulated genes in PCa tissues, and some of them correlated with the abundance of the order Lactobacillales in mouse gut. The expression of sphingosine 1-phosphate receptor 2, which is associated with the order Lactobacillales and cancer progression in mouse models, was inversely associated with aggressive phenotype and weight gain in patients with PCa using the NCBI Gene Expression Omnibus database. Therefore, SMFA may promote PCa progression with the abundance of specific gut microbial species and overexpression of lipogenic genes in PCa. Therapeutics with alteration of gut microbiota and candidate genes involved in diet-induced PCa progression may be attractive in PCa.
- 3 May 2020
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 16 (5) , 1-7
Acute kidney injury and its impact on renal prognosis after robot‐assisted laparoscopic radical prostatectomy
Background: This study assessed the incidence and impact of acute kidney injury (AKI) on renal prognosis in patients who underwent robot‐assisted laparoscopic radical prostatectomy (RARP).Methods: Medical records of 305 patients treated with RARP were retrospectively reviewed. The patients with postoperative AKIs were dichotomized into early AKI (immediately after surgery) and late AKI (1‐7 days after surgery). The impact of AKIs and their risk factors were statistically assessed.Results: Early and late AKI were observed in 143 (46.9%) and 12 (3.9%) patients, respectively. Hypertension and console time were independent risk factors for early AKI. Among the patients with preoperative eGFR ≥60 mL/min, the eGFR decline 12 months after surgery was significantly greater in patients with early AKI than that without early AKI (−6.8 vs −3.2 mL/min, P = .02).Conclusions: Approximately half of patients developed early AKI after RARP. The patients with early AKI had reduced renal function 12 months after surgery.
- 3 May 2020
- Published by Wiley in The International Journal of Medical Robotics and Computer Assisted Surgery
- Vol. 16 (5) , 1-7
Acute kidney injury and its impact on renal prognosis after robot‐assisted laparoscopic radical prostatectomy
Background: This study assessed the incidence and impact of acute kidney injury (AKI) on renal prognosis in patients who underwent robot‐assisted laparoscopic radical prostatectomy (RARP).Methods: Medical records of 305 patients treated with RARP were retrospectively reviewed. The patients with postoperative AKIs were dichotomized into early AKI (immediately after surgery) and late AKI (1‐7 days after surgery). The impact of AKIs and their risk factors were statistically assessed.Results: Early and late AKI were observed in 143 (46.9%) and 12 (3.9%) patients, respectively. Hypertension and console time were independent risk factors for early AKI. Among the patients with preoperative eGFR ≥60 mL/min, the eGFR decline 12 months after surgery was significantly greater in patients with early AKI than that without early AKI (−6.8 vs −3.2 mL/min, P = .02).Conclusions: Approximately half of patients developed early AKI after RARP. The patients with early AKI had reduced renal function 12 months after surgery.